Eli Lilly Wants No Mention of Zyprexa Plea in Actos Trial

If the jury in an Actos bellwether trial is informed that Eli Lilly and Co. pleaded guilty to a strict-liability misdemeanor for its off-label marketing of Zyprexa, the drugmaker won't be able to get a fair trial, the defendant argued in court papers.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.